Free HPV Vaccination Consent Form Template

Informed Consent and Authorization for Human Papillomavirus (HPV) Vaccination

Patient Informed Consent Documentation

Section 1: Patient, Guardian, and Clinic Information

Section 2: Nature and Purpose of the Vaccination

This document records formal authorization for the administration of the Human Papillomavirus (HPV) vaccine series. HPV is a highly prevalent sexually transmitted infection caused by more than 200 related virus subtypes. Several high-risk subtypes are the principal cause of cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers, as well as genital warts. The currently approved nine-valent HPV vaccine (Gardasil 9, Merck) provides protection against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, covering approximately 90 percent of HPV-related cancers and 90 percent of genital warts. The vaccine is administered via an intramuscular injection into the upper arm (deltoid) or, for younger children, the anterolateral thigh. The clinician will confirm the injection site and dose schedule at the time of administration.

Section 3: Recommended Dosing Schedule

Section 4: Contraindication and Precaution Screening Checklist

Section 5: Potential Adverse Events and Risks

Section 6: Expected Benefits

Completing the full recommended HPV vaccine series is expected to develop active, long-lasting immunity against the HPV subtypes covered by the vaccine, substantially reducing the patient's lifetime risk of developing HPV-related cancers of the cervix, vagina, vulva, penis, anus, and oropharynx, as well as genital warts. Population-level data from countries with high vaccination coverage have shown reductions in cervical cancer incidence of over 85 percent among vaccinated age cohorts. The vaccine does not treat existing HPV infections and is most effective when administered before any potential HPV exposure.

Section 7: Reasonable Alternatives

Section 8: Vaccine Adverse Event Reporting System (VAERS)

Healthcare providers are required by the National Childhood Vaccine Injury Act (NCVIA) to report certain adverse events following vaccination to the Vaccine Adverse Event Reporting System (VAERS), a national post-marketing safety surveillance program managed by the CDC and FDA. Patients and guardians may also independently report any suspected adverse reactions at vaers.hhs.gov or by calling 1-800-822-7967. Reporting an adverse event to VAERS does not constitute a formal determination that the vaccine caused the reported event.

Section 9: Vaccines for Children (VFC) Program Eligibility Disclosure

The Vaccines for Children (VFC) Program is a federally funded program providing vaccines at no cost to children 18 years of age and younger who are Medicaid-eligible, uninsured, underinsured, or of American Indian or Alaska Native heritage. If the patient may qualify for VFC coverage, please inform clinic administrative staff before administration so that the correct vaccine inventory is used and documentation requirements are met. Administration fees may still apply under some VFC programs and insurance arrangements.

Section 10: Vaccine Information Statement (VIS) Acknowledgment

I acknowledge that I have been offered and have read (or had read to me) the current Centers for Disease Control and Prevention (CDC) Vaccine Information Statement (VIS) for the HPV vaccine, published edition in effect as of the date of this consent. Federal law requires that the VIS be provided to the patient or guardian before each dose of the vaccine series. I have been given the opportunity to ask questions about the information in the VIS and my questions have been answered.

Section 11: Post-Injection Observation Acknowledgment

Section 12: Financial Responsibility and Insurance Authorization

I authorize the clinic to bill my insurance provider for vaccine administration services. I understand that I am responsible for any applicable co-payments, deductibles, or non-covered charges as determined by my insurance policy. If the patient is receiving the vaccine through a VFC program voucher, I understand that the vaccine itself is provided at no charge but that administration fees may apply according to the clinic's published fee schedule.

Section 13: Language Access and Interpreter Services

If English is not your primary language or if you require assistance communicating, a qualified medical interpreter is available at no cost. Please notify clinic staff before signing this document if you need language assistance. Translated versions of the CDC VIS are available at cdc.gov/vaccines/hcp/vis/index.html.

Section 14: Patient and Guardian Authorization

I certify that I have read and understand this consent and authorization form, or that it has been read and explained to me. I have been given the opportunity to ask questions and all my questions have been answered to my satisfaction. I authorize the administration of the HPV vaccine to the patient named above and agree to all post-injection observation requirements. If I am signing on behalf of a minor patient, I confirm that I am the parent or legally authorized guardian of the patient.

Section 15: Copy of Consent Acknowledgment

I acknowledge that I have been offered a signed copy of this completed consent form for my own records and that I may request an additional copy at any time from the clinic records department.

Section 16: Signatures and Verification